FDA - Search News

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

FDA approves new pain medication as an alternative to opioids: What to know about Journavx

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

Hosted on MSN · 2h

FDA OK's painkiller designed to end opioids' addiction and overdose risk

Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.

Newsweek on MSN · 3h

What is Non-Opioid Pain Medication? Journavx Approved by FDA

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

FDA upgrades recall of Lay's potato chips

Newsweek on MSN · 2d

Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States

A recall which was issued across nine states has now been given the highest risk classification by the federal agency.

Fortune on MSN · 1d

FDA reclassifies Lay’s potato chips recall to the highest risk level, warning the chips could cause ‘serious adverse health consequences or death’

The FDA has raised the risk level on a recall of Lay’s potato chips to the highest level, warning the recalled product could cause death. The chips were originally recalled last month for containing undeclared milk.

USA Today · 1d

Lay's potato chips recall upgraded to FDA's most serious level. Is Ohio affected?

The FDA elevated Lay's Classic Potato Chips to the highest risk level. Here what to know, and whether the recall impacts Ohio.

2don MSN

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

20h

US FDA Identifies Cybersecurity Risks in Certain Patient Monitors

(Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks ...

17h

US FDA approves Axsome Therapeutics' migraine drug

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

FDA Recalls Blood Pressure Drug Over ‘Visible Black’ Contaminants

Medicine may not be an exact science, but precision is crucial for patient care. That’s why the presence of unknown particles ...

19hOpinion

Do food warning labels actually work? Answering your questions.

Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...

Chocolate Recalled in 3 States Over Possible 'Life-Threatening' Reaction

A chocolate-covered pretzel product is being recalled in three states due to the presence of an undeclared milk allergen.

17h

Axsome Shares Up Post Market After Hitting Record High on FDA Approval

Shares of Axsome Therapeutics rose post-market after the company received approval for Symbravo from the Food and Drug Administration. Symbravo, for the acute treatment of migraine with or without ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

FDA upgrades recall of Lay's potato chips

Related topics